Clinical Trial Update: Cellular Therapy for Extreme Preterm Infants at Risk of Developing Bronchopulmonary Dysplasia [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating cellular therapy to prevent bronchopulmonary dysplasia in extreme preterm infants; the study is currently active but not rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Bronchopulmonary Dysplasia | Phase 1 | Status: ACTIVE_NOT_RECRUITING